Washington Trust Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$113K Sell
1,583
-501
-24% -$39.5K 0.01% 279
2025
Q4
$171K Hold
2,084
0.01% 235
2025
Q3
$157K Buy
2,084
+49
+2% +$3.65K 0.01% 243
2025
Q2
$151K Sell
2,035
-2
-0.1% -$139 0.01% 221
2025
Q1
$164K Sell
2,037
-14
-0.7% -$1.2K 0.01% 208
2024
Q4
$160K Sell
2,051
-738
-26% -$62.7K 0.01% 212
2024
Q3
$262K Sell
2,789
-4
-0.1% -$336 0.02% 178
2024
Q2
$218K Sell
2,793
-230
-8% -$18.8K 0.02% 187
2024
Q1
$275K Buy
3,023
+10
+0.3% +$832 0.03% 165
2023
Q4
$233K Sell
3,013
-306
-9% -$21.4K 0.02% 179
2023
Q3
$226K Sell
3,319
-538
-14% -$39.1K 0.02% 173
2023
Q2
$313K Buy
3,857
+40
+1% +$3.19K 0.03% 144
2023
Q1
$313K Buy
+3,817
New +$273K 0.03% 146

Other funds holding GEHC

Washington Trust Advisors's GEHC Position: Q1 2026 in Review

Washington Trust Advisors reduced its GE HealthCare (GEHC) stake by 24% in Q1 2026, selling an estimated $39.5K and leaving 1,583 shares worth $113K. The position accounts for 0.01% of the portfolio, ranked #279.

Washington Trust Advisors first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $313K in Q2 2023. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Washington Trust Advisors held 1,583 shares of GE HealthCare worth $113K as of Q1 2026.
  • Washington Trust Advisors sold 501 GE HealthCare shares in Q1 2026, an estimated $39.5K.
  • GE HealthCare made up 0.01% of Washington Trust Advisors's portfolio in Q1 2026, its #279 holding.
  • Washington Trust Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Washington Trust Advisors's GE HealthCare position peaked at $313K in Q2 2023.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Washington Trust Advisors's 13F filing for Q1 2026, filed 6 Apr 2026.